Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.

Insinga, Ralph P; Dasbach, Erik J; Elbasha, Elamin H

Insinga, Ralph P; Dasbach, Erik J; Elbasha, Elamin H.

Affiliation

Insinga RP; Department of Health Economic Statistics, Merck Research Laboratories, Blue Bell, PA 19422, USA. ralph_insinga@merck.com

Pharmacoeconomics ; 23(11): 1107-22, 2005.

Article in En | MEDLINE | ID: mdl-16277547

Subject(s)

Papillomavirus Infections/economics; Uterine Cervical Dysplasia/economics; Uterine Cervical Neoplasms/economics; Warts/economics; Costs and Cost Analysis; Female; Humans; Papillomavirus Infections/prevention & control; Papillomavirus Infections/transmission; United States/epidemiology; Vaginal Smears

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Warts / Uterine Cervical Dysplasia / Uterine Cervical Neoplasms / Papillomavirus Infections Type of study: Health_economic_evaluation / Prognostic_studies / Systematic_reviews Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: Pharmacoeconomics Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2005 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links